CBG166
/ Carbiogene Therap
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
November 05, 2024
Clinical Trial of Autologous GPC3 CAR-T Cells (CBG166) Therapy for Advanced Hepatocellular Carcinoma
(clinicaltrials.gov)
- P1 | N=15 | Recruiting | Sponsor: Zhejiang University | Not yet recruiting ➔ Recruiting
CAR T-Cell Therapy • Enrollment open • Metastases • Hepatocellular Cancer • Oncology • Solid Tumor
June 17, 2024
Clinical Trial of Autologous GPC3 CAR-T Cells (CBG166) Therapy for Advanced Hepatocellular Carcinoma
(clinicaltrials.gov)
- P1 | N=15 | Not yet recruiting | Sponsor: Zhejiang University
CAR T-Cell Therapy • Metastases • New P1 trial • Gastrointestinal Cancer • Hepatocellular Cancer • Oncology • Solid Tumor
1 to 2
Of
2
Go to page
1